glp-1 bmi 25 New weight-loss drugs surge in popularity amid obesity surge in US, worldwide Frontiers | GLP−1 receptor agonists
Description
Several GLP-1 receptor agonists are FDA-approved for glycemic control in T2D
Each group of BV2 cell supernatants was collected, and the LDH concentration was determined using an LDH assay kit (Nanjing KeyGen Biotech Co., Ltd.) according to the manufacturer's instructions
doi: 10.1111/jdi.12275 [DOI] [PMC free article] [PubMed] [Google Scholar] 75
Side Effects and Tolerability The side effects of tirzepatide and semaglutide overlap because both medications affect appetite and digestion
Kaynak: NEJM Eyll 2025
